Sign in to continue:

Wednesday, April 15th, 2026

Soluna Holdings, Inc. 8-K Filing: Company Details, Nasdaq Listing, and Compliance Statement (April 2026)

Soluna Holdings, Inc. Receives Nasdaq Notice Regarding Minimum Bid Price Deficiency

Key Points:

  • Soluna Holdings, Inc. (NASDAQ: SLNH) received a formal notice from The Nasdaq Stock Market LLC stating the company has been out of compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
  • The deficiency was triggered because the closing bid price for Soluna’s common stock has been below \$1.00 per share for the prior 30 consecutive business days.
  • This notice does not have an immediate impact on the company’s listing or trading on the Nasdaq Capital Market.
  • Soluna now has 180 calendar days, or until October 7, 2026, to regain compliance by having the closing bid price at or above \$1.00 per share for a minimum of ten consecutive business days within this 180-day period.
  • If the company is unable to comply by the deadline, it may qualify for a second 180-day compliance period, subject to meeting certain Nasdaq criteria. If not, Nasdaq will notify Soluna of its intent to delist the common stock, with an option for Soluna to appeal the decision to a Nasdaq hearings panel.
  • The company has stated its intention to actively monitor the closing bid price and may consider implementing available strategies to regain compliance if appropriate.

Details Investors & Shareholders Need to Know

  • Price-Sensitive Information: This development directly relates to Soluna’s continued listing on the Nasdaq Capital Market, which is critical for liquidity, visibility, and institutional investment. Delisting could significantly impact the company’s share value and investor confidence.
  • Potential Corporate Actions: The company may consider actions such as a reverse stock split or other measures to boost the share price if necessary to meet compliance. However, no specific strategy has been announced at this time.
  • No Impact on Trading Yet: As of the filing date, the notice does not affect current trading of Soluna’s common stock or its 9.0% Series A Cumulative Perpetual Preferred Stock (trading symbol: SLNHP), both of which remain listed on Nasdaq.
  • Ongoing Monitoring: Management is aware of the issue and has formally stated its intention to monitor the situation and take action as appropriate to maintain its listing status.

Company Profile and Securities Information

  • Company Name: Soluna Holdings, Inc.
  • Trading Symbols: SLNH (Common Stock), SLNHP (9.0% Series A Cumulative Perpetual Preferred Stock)
  • Exchange: The Nasdaq Stock Market LLC
  • Common Stock Par Value: \$0.001 per share
  • Preferred Stock Par Value: \$0.001 per share
  • Date of Notice: April 10, 2026
  • Date of Report Filing: April 14, 2026

What This Means for Shareholders

This notice is a significant and price-sensitive development. If Soluna Holdings, Inc. fails to regain compliance with Nasdaq’s listing requirements within the prescribed period, the company’s common stock could be delisted from the Nasdaq Capital Market. Delisting would likely reduce share liquidity and could lead to a decrease in share price due to lower visibility and potential limits on institutional investment.

Investors should monitor the company’s announcements for any updates regarding actions to regain compliance, such as potential reverse stock splits or other corporate measures. Management’s proactive approach is a positive sign, but the situation remains unresolved and could have material impacts on shareholder value.



Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with a financial advisor before making investment decisions. The information presented is based on the latest SEC filings and is subject to change without notice. Neither the author nor this publication assumes any responsibility or liability for investor actions taken based on this article.


View Soluna Holdings, Inc Historical chart here



REGENXBIO Inc. 2025 Annual Report: Business Overview, Risk Factors, Financials, and Market Data

REGENXBIO Inc. 2025 Annual Report: Investor Highlights R...

Werewolf Therapeutics Explores Strategic Alternatives Including Sale, Merger, or Partnerships to Maximize Stockholder Value

Werewolf Therapeutics Initiates Review of Strategic Alternat...

   Ad